| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 37.79× | 37.79× | 38.67× | 42.50× | 28.61× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.74× | 0.65× | 0.69× | 0.79× | 1.12× | ||
| 0.29× | 0.29× | 0.31× | 0.33× | 0.39× | ||
| 0.97× | 0.97× | 1.13× | 1.07× | 1.16× | ||
| 0.91× | 0.91× | 0.99× | 0.93× | 0.95× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 28.61 | 42.50 | 38.67 | 37.79 | 37.79 | |
| Working Capital Turnover | 1.12 | 0.79 | 0.69 | 0.65 | 0.74 | |
| Asset Turnover | 0.39 | 0.33 | 0.31 | 0.29 | 0.29 | |
| Cash Conversion (CFO/Net Income) | 1.16 | 1.07 | 1.13 | 0.97 | 0.97 | |
| CFO/EBITDA | 0.95 | 0.93 | 0.99 | 0.91 | 0.91 |